1. Association AD. 5. Prevention or delay of type 2 diabetes: standards ofmedical care in diabetes-2018. Diabetes care. 2018;41(Supplement_1):S51-S54.
2. Jagannathan R, Sevick MA, Li H, et al. Elevated 1-hour plasma glucoselevels are associated with dysglycemia, impaired beta-cell function, andinsulin sensitivity: a pilot study from a real world health care setting.Endocrine. 2016;52(1):172-175.
3. Priya MM, Amutha A, Pramodkumar T, et al. β-Cell function andinsulin sensitivity in normal glucose-tolerant subjects stratified by1-hour plasma glucose values. Diabetes Technology & Therapeutics.2016;18(1):29-33.
4. Tabák AG, Herder C, Rathmann W, Brunner EJ, Kivimäki M.Prediabetes: a high-risk state for diabetes development. Lancet.2012;379(9833):2279-2290.
5. Buysschaert M, Bergman M, Valensi P. 1-h post-load plasma glucose fordetecting early stages of prediabetes. Diabetes Metab. 2022;48(6):101395.
6. Bergman M, Manco M, Sesti G, et al. Petition to replace currentOGTT criteria for diagnosing prediabetes with the 1-hour post-loadplasma glucose≥ 155 mg/dl (8.6 mmol/L). Diabetes Res Clinic Pract.2018;146:18-33.
7. Succurro E, Marini MA, Arturi F, et al. Elevated one-hour post-loadplasma glucose levels identifies subjects with normal glucose tolerancebut early carotid atherosclerosis. Atherosclerosis. 2009;207(1):245-249.doi:10.1016/j.atherosclerosis.2009.04.006
8. Wu X, Chen H, Wang Y, Li H. The relationship between coronary riskfactors and elevated 1-h postload plasma glucose levels in patients withestablished coronary heart disease. Clin Endocrinol (Oxf). 2013;78(1):67-72.
9. Paddock E, Looker HC, Piaggi P, Knowler WC, Krakoff J, Chang DC.One-hour plasma glucose compared with two-hour plasma glucose inrelation to diabetic retinopathy in American Indians. Diabetes Care.2018;41(6):1212-1217.
10. Badimon L, Vilahur G. Thrombosis formation on atherosclerotic lesionsand plaque rupture. J Int Med. 2014;276(6):618-632.
11. Chu S, Becker R, Berger P, et al. Mean platelet volume as a predictor ofcardiovascular risk: a systematic review and meta-analysis. J ThrombosisHaemostasis. 2009;8(1):148-156.
12. Korniluk A, Koper-Lenkiewicz OM, Kaminska J, Kemona H, Dymicka-Piekarska V. Mean platelet volume (MPV): new perspectives for anold marker in the course and prognosis of inflammatory conditions.Mediators Inflam. 2019;2019:1-14.
13. Shimodaira M, Niwa T, Nakajima K, Kobayashi M, Hanyu N, NakayamaT. Correlation between mean platelet volume and fasting plasma glucoselevels in prediabetic and normoglycemic individuals. CardiovascDiabetol. 2013;12:1-7.
14. Coban E, Kucuktag S, Basyigit S. Platelet activation in subjects withimpaired glucose tolerance. Platelets. 2007;18(8):591-594.
15. Nording HM, Seizer P, Langer HF. Platelets in inflammation andatherogenesis. Front Immunol. 2015;6:98.
16. Mertoglu C, Gunay M. Neutrophil-Lymphocyte ratio and Platelet-Lymphocyte ratio as useful predictive markers of prediabetes anddiabetes mellitus. Diabetes Metab Syndr. 2017;11(Suppl 1):S127-S131.
17. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco LJ. Sexdifference in the effects of sociocultural status on diabetes andcardiovascular risk factors in Mexican Americans: the San AntonioHeart Study. Am J Epidemiol. 1984;120(6):834-851.
18. Bardini G, Dicembrini I, Cresci B, Rotella CM. Inflammation markersand metabolic characteristics of subjects with 1-h plasma glucose levels.Diabetes Care. 2010;33(2):411-413.
19. Succurro E, Arturi F, Lugara M, et al. One-hour postload plasma glucoselevels are associated with kidney dysfunction. Clin J Am Soc Nephrol.2010;5(11):1922-1927.
20. Succurro E, Arturi F, Grembiale A, et al. One-hour post-load plasmaglucose levels are associated with elevated liver enzymes. NMCD.2011;21(9):713-718. doi:10.1016/j.numecd.2011.02.002
21. Abdul-Ghani MA, Williams K, DeFronzo RA, Stern M. What is the bestpredictor of future type 2 diabetes? Diabetes Care. 2007;30(6):1544-1548.
22. Abdul-Ghani MA, Abdul-Ghani T, Müller G, et al. Role of glycatedhemoglobin in the prediction of future risk of T2DM. J Clin EndocrinolMetab. 2011;96(8):2596-2600.
23. Galimzhanov A, Tenekecioglu E, Rustamova F, Tun HN, Mamas MA.The prognostic utility of mean platelet volume in patients with acutecoronary syndrome: a systematic review with meta-analyses. Angiology.2022;73(8):734-743.
24. Xue W, Li Y, Xia H, Yu T, Sun S, Zhang M. Influence of neutrophil-to-lymphocyte ratio and mean platelet volume on severity and short-termprognosis of acute ischemic stroke. Am J Transl Res. 2022;14(6):4066.
25. Li F, Ye P, Hao Y, et al. A PCSK9 inhibitor induces a transient decrease in theneutrophil-lymphocyte ratio and monocyte-lymphocyte ratio in homozygousfamilial hypercholesterolemia patients. Atheroscler Plus. 2022;49:12-19.
26. Oğlak SC, Tunç Ş, Ölmez F. First trimester mean platelet volume,neutrophil to lymphocyte ratio, and platelet to lymphocyte ratio values areuseful markers for predicting preeclampsia. Ochsner J. 2021;21(4):364-370.
27. Inaoka K, Kanda M, Uda H, et al. Clinical utility of the platelet-lymphocyte ratio as a predictor of postoperative complicationsafter radical gastrectomy for clinical T2-4 gastric cancer. World JGastroenterol. 2017;23(14):2519.
28. Coban E, Ozdogan M, Yazicioglu G, Akcit F. The mean platelet volume inpatients with obesity. Int J Clin Pract. 2005;59(8):981-982.
29. Park HS, Park JY, Yu R. Relationship of obesity and visceral adipositywith serum concentrations of CRP, TNF-α and IL-6. Diabetes Res ClinPract. 2005;69(1):29-35.
30. Grossmann V, Schmitt VH, Zeller T, et al. Profile of the immune andinflammatory response in individuals with prediabetes and type 2diabetes. Diabetes Care. 2015;38(7):1356-1364.
31. Maschirow L, Khalaf K, Al-Aubaidy H, Jelinek H. Inflammation,coagulation, endothelial dysfunction and oxidative stress in prediabetes-Biomarkers as a possible tool for early disease detection for ruralscreening. Clinic Biochemistry. 2015;48(9):581-585.
32. Wang Z, Shen X-H, Feng W-M, Ye G-f, Qiu W, Li B. Analysis ofinflammatory mediators in prediabetes and newly diagnosed type 2diabetes patients. J Diabetes Res. 2016:2016:7965317.
33. Johnson JL, Duick DS, Chui MA, Aldasouqi SA. Identifying prediabetesusing fasting insulin levels. Endocrine Pract. 2010;16(1):47-52.
34. Tabák AG, Jokela M, Akbaraly TN, Brunner EJ, Kivimäki M, Witte DR.Trajectories of glycaemia, insulin sensitivity, and insulin secretion beforediagnosis of type 2 diabetes: an analysis from the Whitehall II study.Lancet. 2009;373(9682):2215-2221.
35. Vozarova B, Weyer C, Lindsay RS, Pratley RE, Bogardus C, TataranniPA. High white blood cell count is associated with a worsening of insulinsensitivity and predicts the development of type 2 diabetes. Diabetes.2002;51(2):455-461.
36. Mauer J, Chaurasia B, Goldau J, et al. Signaling by IL-6 promotesalternative activation of macrophages to limit endotoxemia and obesity-associated resistance to insulin. Nat Immunol. 2014;15(5):423-430.
37. Rehman K, Akash MSH, Liaqat A, Kamal S, Qadir MI, Rasul A. Role ofinterleukin-6 in development of insulin resistance and type 2 diabetesmellitus. Critical Reviews™ in Eukaryotic Gene Expression. 2017;27(3):229-236.